These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2093115)

  • 1. Activity of cilofungin (LY 121019), a new lipopeptide antibiotic, on the cell wall and cytoplasmic membrane of Candida albicans. Structural modifications in scanning and transmission electron microscopy.
    Drouhet E; Dupont B; Improvisi L; Lesourd M; Prevost MC
    J Med Vet Mycol; 1990; 28(6):425-36. PubMed ID: 2093115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lipopeptide antimycotic, cilofungin modulates the incorporation of glucan-associated proteins into the cell wall of Candida albicans.
    Angiolella L; Simonetti N; Cassone A
    J Antimicrob Chemother; 1994 Jun; 33(6):1137-46. PubMed ID: 7928807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative activity in vitro of cilofungin (LY 121019) with other agents used for treatment of deep-seated Candida infections.
    Rennie RP; Hellman L
    Mycoses; 1989 Mar; 32(3):145-50. PubMed ID: 2733726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of cilofungin as direct fluorescent probe for monitoring antifungal drug-membrane interaction.
    Ko YT; Ludescher RD; Frost DJ; Wasserman BP
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1378-85. PubMed ID: 8092841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cilofungin (LY121019), a fungal cell wall synthesis inhibitor, on interactions of Candida albicans with human neutrophils.
    Meshulam T; Levitz SM; Diamond RD; Sugar AM
    J Antimicrob Chemother; 1989 Nov; 24(5):741-5. PubMed ID: 2689424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cilofungin (LY121019) on carbohydrate and sterol composition of Candida albicans.
    Pfaller M; Riley J; Koerner T
    Eur J Clin Microbiol Infect Dis; 1989 Dec; 8(12):1067-70. PubMed ID: 2695329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucan synthesis and its inhibition by cilofungin in susceptible and resistant strains of Candida albicans.
    Angiolella L; Bromuro C; Simonetti N; Cassone A
    J Med Vet Mycol; 1992; 30(5):369-76. PubMed ID: 1469538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cilofungin (LY121019), an antifungal agent with specific activity against Candida albicans and Candida tropicalis.
    Hall GS; Myles C; Pratt KJ; Washington JA
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1331-5. PubMed ID: 3058017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of human neutrophil phagocytosis of Candida albicans by a beta-glucan synthase inhibitor, cilofungin.
    Richardson MD; Smyth LA; Shankland GS
    FEMS Microbiol Immunol; 1991 Oct; 3(5):299-303. PubMed ID: 1797051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro activity of cilofungin (LY121019) in comparison with amphotericin B.
    Meunier F; Lambert C; Van der Auwera P
    J Antimicrob Chemother; 1989 Sep; 24(3):325-31. PubMed ID: 2681118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cilofungin on phagocytosis and intracellular killing of Candida albicans by human neutrophils.
    Richardson MD; Scott G; Shankland GS
    Eur J Clin Microbiol Infect Dis; 1992 Jan; 11(1):22-6. PubMed ID: 1563379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the lipopeptide antibiotic, iturin A, on morphology and membrane ultrastructure of yeast cells.
    Thimon L; Peypoux F; Wallach J; Michel G
    FEMS Microbiol Lett; 1995 May; 128(2):101-6. PubMed ID: 7750727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The activity of cilofungin on the incorporation of glucan associated proteins into hyphal cells of Candida albicans.
    Angiolella L; Facchin M; Simonetti N; Cassone A
    J Chemother; 1995 Apr; 7(2):83-9. PubMed ID: 7666125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cilofungin (LY121019) inhibits Candida albicans (1-3)-beta-D-glucan synthase activity.
    Taft CS; Stark T; Selitrennikoff CP
    Antimicrob Agents Chemother; 1988 Dec; 32(12):1901-3. PubMed ID: 2977537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of Candida species to cilofungin (LY-121019).
    Torres-Rodriguez JM; Carrillo-Muñoz A; Gallach-Bau C; Madrenys N
    Mycoses; 1989 Jun; 32(6):316-8. PubMed ID: 2779613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of aculeacin A and papulacandin B on morphology and cell wall ultrastructure in Candida albicans.
    Bozzola JJ; Mehta RJ; Nisbet LJ; Valenta JR
    Can J Microbiol; 1984 Jun; 30(6):857-63. PubMed ID: 6386132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a glucan-associated enolase as a main cell wall protein of Candida albicans and an indirect target of lipopeptide antimycotics.
    Angiolella L; Facchin M; Stringaro A; Maras B; Simonetti N; Cassone A
    J Infect Dis; 1996 Mar; 173(3):684-90. PubMed ID: 8627033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro comparison of cilofungin alone and in combination with other antifungal agents against clinical isolates of Candida species.
    Smith KR; Lank KM; Dismukes WE; Cobbs CG
    Eur J Clin Microbiol Infect Dis; 1991 Jul; 10(7):588-92. PubMed ID: 1655435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphological changes of Candida albicans induced by micafungin (FK463), a water-soluble echinocandin-like lipopeptide.
    Nishiyama Y; Uchida K; Yamaguchi H
    J Electron Microsc (Tokyo); 2002; 51(4):247-55. PubMed ID: 12227555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysis of growing yeast-form cells of Candida albicans by echinocandin: a cytological study.
    Cassone A; Mason RE; Kerridge D
    Sabouraudia; 1981 Jun; 19(2):97-110. PubMed ID: 7020114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.